Legacy Private Trust Co. Sells 4,368 Shares of Danaher Corporation $DHR

Legacy Private Trust Co. lessened its holdings in Danaher Corporation (NYSE:DHR) by 19.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,365 shares of the conglomerate’s stock after selling 4,368 shares during the quarter. Legacy Private Trust Co.’s holdings in Danaher were worth $3,628,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the business. MGO One Seven LLC grew its stake in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after buying an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher in the first quarter worth $539,000. UniSuper Management Pty Ltd grew its stake in shares of Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after acquiring an additional 2,667 shares during the last quarter. Horizon Financial Services LLC increased its holdings in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock valued at $1,681,000 after acquiring an additional 8,160 shares in the last quarter. Finally, Texas Capital Bank Wealth Management Services Inc raised its position in shares of Danaher by 6.1% in the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate’s stock worth $7,126,000 after purchasing an additional 2,009 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on DHR shares. Evercore ISI reduced their price objective on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research note on Tuesday, July 8th. UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Wells Fargo & Company decreased their price objective on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. Robert W. Baird upped their price objective on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research report on Friday, July 18th. Finally, Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a report on Friday, July 11th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $246.35.

Danaher Stock Performance

DHR stock opened at $190.07 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a market cap of $136.10 billion, a P/E ratio of 40.44, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. The stock’s fifty day moving average price is $201.21 and its 200-day moving average price is $198.78.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the company earned $1.72 earnings per share. Danaher’s revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.20% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.